J Korean Ophthalmol Soc > Volume 50(9); 2009 > Article
Journal of the Korean Ophthalmological Society 2009;50(9):1295-1300.
DOI: https://doi.org/10.3341/jkos.2009.50.9.1295    Published online September 15, 2009.
Effectiveness for Intralesional Triamcinolne Acetonide Injections for Chalazia in Pediatric Patients.
Ju Hong Park, Jun Hyuk Son
Department of Ophthalmology, Yeungnam university College of Medicine, Daegu, Korea. sjh@med.yu.ac.kr
소아 환자에서 콩다래끼 병소내에 시행한 스테로이드 국소주사의 유효성
박주홍ㆍ손준혁
Department of Ophthalmology, Yeungnam university College of Medicine, Daegu, Korea
Abstract
PURPOSE
To evaluate the effectiveness of intralesional triamcinolone acetonide injection for chalazia in pediatric patients. METHODS: We performed a retrospective chart review of 58 patients (70 lesions) under fifteen years of age and 40 patients (50 lesions) aged fifteen and over, who underwent intralesional triamcinolone acetonide injections and performed follow-ups for at least three months between January 2007 and October 2008. Data regarding age, sex, lesion size, location, number of injections, treatment success, surgery, and complications were evaluated. RESULTS: Cumulative treatment success of TA was 64.3% with the first injection, 82.9% with a second injection, and 88.6% with a third injection in patients under fifteen years of age. The average number of TA injections was 1.67+/-1.03 in primary chalazia and 1.48+/-0.87 in recurrent chalazia, while the cumulative treatment success until third TA injection was 89.8% in primary chalazia and 85.7% in recurrent chalazia inpatients under fifteen years old. The average number of TA injections was 1.95+/-1.18 in primary chalazia and 1.80+/-1.14 in recurrent chalazia, while the cumulative treatment success until the third TA injection was 82.5% in primary chalazia and 70.0% in recurrent chalazia in patients aged fifteen and over. No complications were noted with TA injections. CONCLUSIONS: Intralesional triamcinolone acetonide injection in chalazia is an effective and safe treatment in pediatric patients.
Key Words: Chalazion;Intralesional injection;Triamcinolone acetonide


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next